Mayo Clinic News Network

News Resources

Ginger Plumbo (@gplumbo)

Activity by Ginger Plumbo

Ginger Plumbo (@gplumbo) posted · Tue, Jul 28 6:00am · View  

Mayo Clinic releases findings and treatment criteria for use of left-ventricular assist devices on heart failure patients

heart transplant surgery ROCHESTER, Minn. — Mayo Clinic is announcing results of a study on the effectiveness of left-ventricular assist devices (LVAD) in treating patients with a form of cardiomyopathy called restrictive cardiomyopathy (RCM). The Mayo Clinic study, which is the largest study of its kind to date, demonstrates that LVAD devices are a viable and accessible option for treating patients with RCM, who would otherwise see their health deteriorate or who may not survive. The study suggests criteria that clinicians can use for successful implementation of these devices in RCM.

Approximately 500,000 people are currently living with cardiomyopathy, which is a condition that affects the muscles in the heart. RCM is a rare form of cardiomyopathy that limits the heart muscle from relaxing between beats when the blood returns from the body back to the heart. This causes the heart to pump weakly and restricts the flow of blood to the heart’s chambers. An LVAD is a mechanical pump that helps pump blood from the heart to the rest of the body.

MEDIA CONTACT: Ginger Plumbo, Mayo Clinic Public Affairs, 507-284-5005, Email: [...]

Click here to view the rest of the post

Login here to comment.

Ginger Plumbo (@gplumbo) posted · Wed, Jul 15 11:13am · View  

Researchers Test Bioartificial Liver Device to Treat Acute Liver Failure

ROCHESTER, Minn. — Approximately 30,000–40,000 people die from liver disease each year, according to the American Liver Foundation. For people who experience acute liver failure, the only proven treatment has been liver transplantation. Researchers at Mayo Clinic have developed and are testing an alternative to liver transplantation called the Spheroid Reservoir Bioartificial Liver that can support healing and regeneration of the injured liver, and improve outcomes and reduce mortality rates for patients with acute liver failure --without requiring a transplant.

bioliver slideDeveloped by Scott Nyberg, M.D., Ph.D., principal investigator in the Artificial Liver and Liver Transplantation Laboratory at Mayo Clinic, and liver transplant surgeon, the device uses healthy hepatocytes, or liver cells, from pigs to do the job of a normal, healthy liver, which aids in digestion and the removal of waste and toxins from the bloodstream. Treatment with the Spheroid Reservoir Bioartificial Liver (SRBAL) has been shown to reduce the severity of liver disease and improve survival in pigs. Future clinical studies are planned to assess the SRBAL as a less-invasive, long-term treatment option to liver transplantation. Results from a study using the device in a pivotal preclinical trial were published today in the Journal of Hepatology.

To see how the device works and access exclusive video of researchers in Mayo's laboratories, click here.

MEDIA CONTACT: Ginger Plumbo, Mayo Clinic Public Affairs, 507-284-5005, Email: [...]

Click here to view the rest of the post

Login here to comment.

Ginger Plumbo (@gplumbo) posted · Thu, May 14 11:10am · View  

Mayo Clinic Study Finds Losing Weight Can Reduce Risk of Death and Ventilator Use in Lung Transplant Patients

ROCHESTER, Minn. — Obesity is a complicating factor for many surgical patients. In a recent study published in the Journal of Heart and Lung Transplantation, Mayo Clinic researchers have shown that losing weight can have a positive impact on outcomes for lung transplant patients.

Image of heart transplant surgeryIn the manuscript, “Weight loss prior to lung transplantation is associated with improved survival,” Mayo Clinic researchers showed that a one unit reduction in body mass index in overweight and obese lung transplant recipients resulted in a reduced risk of death. The study also showed overweight and obese patients who lost weight spent less time on a mechanical ventilator after transplantation surgery.

“We knew from past research that obesity complicates post-transplant outcomes and survival,” says Cassie Kennedy, M.D., Mayo Clinic pulmonologist and transplant researcher. “Many practices advocated delaying transplant listing for obese patients to allow for weight loss, but we didn’t know if losing weight prior to transplantation was realistic. Patients awaiting lung transplantation have functional limitations that might impede weight loss. We also did not know if weight loss before lung transplant could actually help transplant patients live longer and avoid complications. This study showed weight loss in overweight and obese patients was achievable, sustained six to 12 months post-surgery, and that these individuals had improved survival and fewer complications related to their transplant procedure.”

MEDIA CONTACT: Ginger Plumbo, Mayo Clinic Public Affairs, 507-284-5005, Email:


Click here to view the rest of the post

Login here to comment.

Ginger Plumbo (@gplumbo) posted · Tue, May 5 2:48pm · View  

Mayo Clinic Physicians to Present Research Findings From Late-breaking Transplant Studies at American Transplant Congress

ROCHESTER, Minn. — Mayo Clinic transplant researchers will present findings from nearly 20 studies at the American Transplant Congress in Philadelphia, Penn., May 2-5.

Mayo Clinic is nationally recognized for research and clinical success in transplantation, and performs over 1,000 solid organ transplants each year. Researchers will share findings from the following late-breaking studies at the American Transplant Congress:

“Burden of Early Antibody-Mediated Rejection (AMR): Complications, Resource Utilization and Cost Differential in Treatment of AMR”
Mayo Clinic surgeons at work

  • This study examined the connection between early AMR (a situation following transplant surgery in which the body begins to reject the donor organ) and clinical complications, hospital resource utilization and related costs.
  • An examination of 48 adult patients with AMR found those who were diagnosed with early AMR experienced higher rates of complications, almost double the number of hospital days and surgical procedures, and significantly higher post-transplant health care costs.
  • Mayo Clinic researchers involved in this study include Ramandeep Banga, MBBS, Carrie Schinstock, M.D., Matthew Hathcock, Walter Kremers, Ph.D., and Mark Stegall, M.D.
  • Presentation Date: May 2, 5:30 p.m. to 7:30 p.m. EDT

MEDIA CONTACT: Ginger Plumbo, Mayo Clinic Public Affairs, 507-284-5005, Email: [...]

Click here to view the rest of the post

Login here to comment.

Ginger Plumbo (@gplumbo) posted · Mon, Apr 20 1:46pm · View  

Mayo Clinic Physicians Present New Research on Heart Transplant Care and Long-term Outcomes

ROCHESTER, Minn. — Heart transplant experts from Mayo Clinic presented findings from three recent clinical studies involving heart transplant patients. The presentations took place during the 2015 International Society of Heart & Lung Transplant (ISHLT) in Nice, France, April 15–18.

Two hands holding a heartMayo Clinic physicians presented oral and poster presentations on 16 studies at ISHLT this year. The conference attracts 3,000 health care professionals from 45 countries who represent more than 15 different medical disciplines involved in the management and treatment of end-stage heart and lung disease. A few highlights of the Mayo Clinic-related research include:

“Are psychosocial characteristics predictive of death and rehospitalization after destination left ventricular assist device?”

  • This study examined psychosocial factors, such as drug use, depression and nonsmoking status to determine if they are associated with higher rehospitalization risk after a patient has received a left ventricular assist device (LVAD).
  • The study concluded that drug use, depression and nonsmoking status are associated with higher rehospitalization risk after LVAD. These data may be helpful in stratifying and communicating risk to patients who are considering LVAD as destination therapy.
  • Mayo Clinic researchers involved in this study include Shannon Dunlay, M.D., M.S.; Sarah Schettle, PAC; David Snipelisky, M.D.; Shashank Sharma; Sudhir Kushwaha, M.D.; John Stulak, M.D.
  • Date of presentation: April 15


Click here to view the rest of the post

Login here to comment.

Ginger Plumbo (@gplumbo) posted · Wed, Apr 15 3:16pm · View  

April 17 is ‘Donate Life Day’ in Rochester

Wear blue and green, attend ‘Walk of Remembrance’ and flag ceremony to commemorate

ROCHESTER, Minn. — Friday, April 17, is “Donate Life Day” in Rochester, an annual recognition to raise awareness about organ donation. LifeSource, Gift of Life Transplant House and Mayo Clinic Transplant Center are hosting a “Walk of Remembrance” and flag ceremony starting at 4:30 p.m. on the Saint Marys Hospital campus. The public is welcome and encouraged to attend.Gift of Life Transplant House

More than 120,000 people are waiting for an organ transplant in the United States. Nearly 2,000 of those are children. Mayo Clinic has over 3,000 patients on the waiting list for an organ transplant. Every 10 minutes another name is added to the national waiting list. An average of 21 people die each day in the United States waiting for transplants that can't take place because of the shortage of donated organs.

Ginger Plumbo, Mayo Clinic Public Affairs, 507-284-5005, Email:

April is National Donate Life Month, and events are happening across the country to increase support for organ, tissue and eye donation. In addition to the Donate Life Day event in Rochester, there are several other ways to participate or observe Donate Life Month: [...]

Click here to view the rest of the post

Login here to comment.

Ginger Plumbo (@gplumbo) posted · Fri, Apr 10 5:19pm · View  

Free Webinar for Donors and Patients on Living-donor Kidney Transplants

Kidney transplant surgeon

Dr. Mikel Prieto

ROCHESTER, Minn. — Prospective kidney transplant patients, families of adult and pediatric transplant candidates, and potential living kidney donors are invited to attend a free, public webinar about living-donor kidney transplants hosted by Mayo Clinic. Mayo Clinic is a leader in kidney transplants, performing approximately 550 kidney transplants each year and has one of the largest living-donor kidney transplant programs in the United States.

“As living organ donation, especially non-directed or ‘Good Samaritan’ donation, becomes more widely known and accepted, we want to provide more information about innovations in donation and transplantation,” says Mikel Prieto, M.D., surgical director of Kidney Transplantation at Mayo Clinic in Rochester, Minnesota. “We also want to provide a forum to answer questions for prospective donors, recipients, and their family members.”

What:  Free Webinar

When:  April 14 at noon CDT

Topic: What Patients and Donors Need to Know About Living-Donor Kidney Transplants

Host:  Mayo Clinic Kidney/Pancreas Transplant Program


MEDIA CONTACT: Ginger Plumbo, Mayo Clinic Public Affairs, 507-284-5005, Email: [...]

Click here to view the rest of the post

Login here to comment.

Ginger Plumbo (@gplumbo) posted · Thu, Oct 9 2014 · View  

News Radio 830 WCCO Broadcasting Live from Mayo Clinic

WCCO will broadcast the Morning Show with Dave Lee from Mayo Clinic on Oct. 10 from 5 to 9 a.m.

ROCHESTER, Minn. — News Radio 830 WCCO joins Mayo Clinic in marking its 150th anniversary with a live broadcast of the Morning Show with Dave Lee on Friday, Oct. 10, 5–9 a.m. from the Landow Atrium in the Gonda Building on the Mayo Clinic campus in Rochester. The public is encouraged to tune in.

'Mayo 150 years serving humanity' 150th Sesquicentennial LogoScheduled* guests include:

WCCO personalities on the broadcast will include Dave Lee, host; Mike Lynch, weather; Sid Hartman, sports; Mike Max, sports.

Lee is the popular, longtime host of The Morning News on WCCO Radio in Minneapolis. He has been with WCCO Radio for more than 20 years. In October 2014, WCCO Radio celebrates its 90th year on the air.


Click here to view the rest of the post

Login here to comment.

Load More    

Loading information...